Search Tag: Long COVID

ICU Management

2024 09 Jun

  In a recent clinical trial, a 15-day course of nirmatrelvir-ritonavir targeting SARS-CoV-2 was found to be safe as an extended-duration treatment. However, it did not alleviate specific symptoms of long COVID. These findings are published in JAMA Internal Medicine.   The combination of nirmatrelvir-ritonavir is approved by the FDA for treating...Read more

Cardiology Management

2023 01 Feb

A study published in Cardiovascular Research found that COVID-19 is associated with a higher risk of cardiovascular disease and death in both the short and long term. In the first three weeks of infection, the likelihood of COVID-19 patients dying was up to 81 times higher than uninfected individuals and remained five times higher up to 18 months later. ...Read more

Executive Health Management

2022 21 Jun

New research shows that the Omicron variant is less likely to cause Long-COVID compared to the Delta variant. The findings are published in The Lancet.  This is the first peer-reviewed study to report the risk of Long-COVID associated with the Omicron variant. As per the NICE guidelines, Long-COVID is defined as new or ongoing symptoms four weeks...Read more

ICU Management

2022 10 May

More than 500 million cases of COVID-19 have been reported worldwide. Patients infected with COVID-19 are at a higher risk of persisting health impairments six months after hospital discharge associated with reduced physical function and health and quality of life. It is thus important to understand the long-term trajectory of recovery from COVID-19....Read more

ICU Management

2022 12 Apr

COVID-19 has had a significant impact on the number of hospital admissions, including many patients presenting acute respiratory failure. Approximately 15% of hospitalised COVID-19 patients require ICU admission.  It is well established that the physical and psychological impact of an ICU stay on patients can be quite significant and prolonged....Read more

Executive Health Management

2022 14 Feb

Many individuals with COVID-19 report symptoms lasting for over four weeks, but for some, these symptoms persist past 12 weeks. Some described extreme fatigue, shortness of breath, cognitive dysfunction, i.e. ‘brain fog’, or a persistent loss of taste or smell.   The prevalence of this symptom cluster, colloquially known as ‘Long-COVID’, has been...Read more